Breakthrough Streptococcus pneumoniae meningitis during clarithromycin therapy for acute otitis media.


Autoria(s): Bochud P.Y.; Calandra T.; Moreillon P.; Baumgartner J.D.; Yersin B.
Data(s)

2001

Identificador

http://serval.unil.ch/?id=serval:BIB_945718F5003E

isbn:0934-9723 (Print)

pmid:11305469

doi:10.1007/s100960000444

isiid:000167531600012

Idioma(s)

en

Fonte

European Journal of Clinical Microbiology and Infectious Diseases, vol. 20, no. 2, pp. 136-137

Palavras-Chave #Adult; Anti-Bacterial Agents/adverse effects; Anti-Bacterial Agents/therapeutic use; Ceftriaxone/therapeutic use; Clarithromycin/adverse effects; Clarithromycin/therapeutic use; Female; Humans; Meningitis, Pneumococcal/chemically induced; Otitis Media/drug therapy; Pneumococcal Infections/drug therapy; Streptococcal Infections/drug therapy; Streptococcus pneumoniae/drug effects
Tipo

info:eu-repo/semantics/article

article